Acucela
discovers and develops therapeutics treatment for sight-threatening ophthalmic diseases... Read moreAcucela
discovers and develops therapeutics treatment for sight-threatening ophthalmic diseases... Read more
News
Mar 31, 2020
BioSpace
Acucela: Company Profile for Kubota Vision Inc. (dba of Acucela Inc.)
Feb 13, 2020
BioPortfolio
Acucela: Acucela Provides Update on Emixustat Phase 3 Clinical Trial in Patients with Stargardt Disease
Feb 03, 2020
BioPortfolio
Acucela: Acucela Meets with NASA and TRISH for Phase 1 Update for SSOCT Project
Jan 06, 2020
BioPortfolio
Acucela: Acucela Announces Publication Assessing the Role of Emixustat Hydrochloride in Retinal Degeneration Treatment
Dec 23, 2019
BioPortfolio
Acucela: Acucela to Participate in Biotech Showcase 2020
Dec 08, 2019
BioPortfolio
Acucela: Acucela Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14122018 Prices from USD $220
Jun 10, 2019
BioPortfolio
Acucela: Acucela gets European orphan designation for emixustat to treat Stargardt disease
May 15, 2019
BioPortfolio
Acucela: Acucela Appoints Robert Bob J. Stevens to its Board of Directors
Mar 19, 2019
SpaceDaily
Acucela: Acucela Signs Agreement to Develop a Compact OCT for NASA's Deep Space Missions
Dec 22, 2018
BioPortfolio
Acucela: Acucela Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14122018 Prices from USD $250
Acucela Competitors
1
2
3
4
5
6
7
8
9
10